JODI HERCHE: Open Payments
NPI 1184348377 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,125 in 58 payments from 18 companies in 2025. Trend: 2023 $505 · 2024 $1,326 · 2025 $1,125
Food & beverage: $1,096Education: $30
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $283 |
| Vanda Pharmaceuticals Inc. | 10 | $172 |
| Corium, LLC | 8 | $127 |
| Lilly USA, LLC | 4 | $74 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Novo Nordisk Inc | 3 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Alkermes, Inc. | 2 | $40 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
Products named: VRAYLAR, FANAPT, Azstarys, COBENFY, JARDIANCE, Auvelity, CAPLYTA, XIFAXAN.
Industry payments across IN — which companies pay providers there.
